adidas AG

  • WKN: A1EWWW
  • ISIN: DE000A1EWWW0
  • Land: Deutschland

Nachricht vom 20.12.2017 | 13:00

DGAP-DD: adidas AG english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

20.12.2017 / 13:00
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Hans
Last name(s): Ruprecht

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
adidas AG

b) LEI
549300JSX0Z4CW0V5023 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A1EWWW0

b) Nature of the transaction
The Supervisory Board member participates in the adidas employee share purchase program. He has agreed with adidas AG to invest an amount of EUR 1,134.49 of his monthly salary in adidas AG shares, as long as he doesn't change or cancel his participation. adidas AG will provide a discount of 15% on the market price of the shares. At the end of each quarter, the plan administrator buys adidas AG shares for the Supervisory Board member from the withholding. At the end of the one-year vesting period, participants will receive matching shares free of charge at a ratio of 1:6.
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)
Price(s) Volume(s)
not numberable not numberable

d) Aggregated information
Price Aggregated volume
not numberable not numberable

e) Date of the transaction
2017-12-15; UTC+1

f) Place of the transaction
Name: Frankfurter Wertpapierbörse (FWB) - Xetra
MIC: XETR



20.12.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

PSI Software AG

Original-Research: PSI AG (von First Berlin Equity Research GmbH): Hinzufügen

06. Dezember 2021